- The FDA just approved a new combination of drugs to treat HIV.
- The treatment combines three drugs into one daily pill:
- The new approval could shake up the $22 billion HIV drug market.
ADVERTISEMENT
A new pill to treat HIV just got approved — and it could shake up a $22 billion market (GILD)
The treatment made by Gilead combines three drugs into one daily pill: bictegravir, emtricitabine and tenofovir alafenamide.
The FDA just approved a new, once-a-day pill to treat HIV.
Up until recently,
In November, the FDA approved a rival treatment that uses two drugs in one pill: . said in a press release
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
ADVERTISEMENT